< img src="https://cdn5.telesco.pe/file/EdM22HaCMAYBgKPVXoRBmoqtXe6rmirBki0_DVBfNZ2u6Xp54OOBj1RUKYKeTdZ29YV9jQmsF9MhPJtvROyp1V1LX9GsRe7c3IMxnqAPGxl8glwUxxWH5kAe165z9t0jl11ud--xhg-IrskjrKPBQOL4fD0LPfQVhiKcQyoTNDlcQoDgULKD_G2PJR36qcRrOLeQ8gwLgp8Ew_rQ51-K6KGfj6sI0pJGW2SkvpE5T1ZI8RG0L2GxFcZkS83T6BuZrTiYi5xj1nLNs2ASK760a48w6MebI7vj4yFrQkWivJA1hf5TFS1jaKfWJ_SwedW_A89uxox7PmfWODU7k9XbVw" alt="" />
谷歌DeepMind旗下AI新药研发公司Isomorphic Labs的首席AI官Max Jaderberg,接受美国红杉资本访谈完整版
@TechBio专属频道:
0 评论